Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus. - Wikidata - awgldk - TriplyDB

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

http://www.wikidata.org/entity/Q34017518

about

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci Targeting Antibiotic Resistance Safety profiles of old and new antimicrobials for the treatment of MRSA infections.Effect of ceftaroline on normal human intestinal microflora.Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.New drugs approved in 2010 In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Reversing resistance: The next generation antibacterials.Ceftaroline in complicated skin and skin-structure infections.Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study Emerging drugs in sepsis.Ceftaroline fosamil: a new broad-spectrum cephalosporin.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Antibiotic resistance in Enterococcus faecium clinical isolates.A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline.Ceftolozane/Tazobactam: A New Cephalosporin and β-Lactamase Inhibitor Combination.Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections.Efficacy, pharmacokinetic and pharmacodynamic profile of ceftolozane + tazobactam in the treatment of complicated urinary tract infections.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.Acute bacterial skin and skin structure infections: current perspective.Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort study.Novel antibiotics for the treatment of Staphylococcus aureus.Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents.Modulation of the antibiotic activity against multidrug resistant strains of 4-(phenylsulfonyl) morpholine.Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin.Analysis of Potential β-Lactam Surrogates to Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae.

P2860

Q24614464-5C482D1E-5D8E-42B3-A3D4-F1DF28F9414A Q26853465-A841CCE5-B122-4F1E-B33A-2CF6F608B10E Q28078130-70102DA8-CA33-4EFB-A043-FB54440464CE Q33429168-7D1FF00B-5512-4EA6-A862-1F25214176C8 Q33826455-F7E2999D-B95B-49CE-8F3F-7DFAA562B7F4 Q33886807-C55625FF-3CAB-4CA4-A198-215FDB22183C Q34325573-5E4F5E44-676A-4A23-9309-01CC0EBACEDA Q34393008-C23D7EA1-8593-42CF-9522-95E736B42268 Q34753085-E431822D-CAB4-4F61-932D-B6C92A7707BB Q35004919-F449F288-2792-46E0-B56E-FFCD8872D827 Q35117981-2257BD03-6B9A-4996-A3DA-97E5C45ABCC0 Q35587135-BA3543CD-7156-4A91-8647-6B2C523C3EEB Q35619094-CB4A2AC5-088A-4637-953C-F492B2914233 Q35669688-A337F1E1-581D-4F30-BAA5-1B45E127B109 Q35715381-0C1A4350-34D9-4AA1-925F-DB67A03DEC6C Q35746176-B13C342D-6A7E-4BD5-B94E-1DBAC1FB21E9 Q35752997-E272B196-6CC6-4471-8D27-127CE676124E Q37263425-6E5BE1A6-7F08-4F13-A851-191376945D77 Q37670186-5E3A6A5A-9586-4414-9BE3-C67E40AA8AF3 Q37863942-C0574A3C-71FA-414A-B20C-7B77C5A7D9AB Q38025132-49AE6246-CB05-424F-911B-B0CD04F13797 Q38117077-C80D2DD3-5C87-4D22-8F3A-616FB40708B2 Q38176042-B0779D75-5BD0-4624-B4AA-5343E6D74E28 Q38458802-611BD094-27F0-4AC9-AFB9-159E153F7844 Q38544744-88F85E97-1658-4534-A68F-5FCACE4372F5 Q38740494-C293C870-AC53-4AC7-BA84-83A810573A2B Q38872130-2D4D520A-9431-4A71-8DDC-E1595E75F85D Q38958278-4D706743-30DD-45DA-AFC4-9A254FC3EBD1 Q39268884-3F5CBBE0-A4CB-4572-9536-9D5B3E205D33 Q39484611-20619308-3554-4322-8A6F-D9ECFBEB2E46 Q39933945-2B92CF0A-24F7-44D9-BA7B-B86518CC2CD6 Q40224839-C8C94EA2-EDD1-46D9-B426-9CB2DD95CC39 Q40335746-E8D97DDB-162A-4246-958B-EE3E402B1B5C Q41423430-F50B2640-783D-41F2-AF9B-4AB8F8DDDF1C Q41767336-7BA62696-9284-4FE7-B258-342292BD0033 Q42790618-D0C53CA6-4896-4275-B092-DFC7E7D481E1 Q42869521-AFAB429B-53A3-49CA-B063-64ECD34F2070 Q50048535-D6800EE8-AC19-4A30-9D00-F37DC6147B77

P2860

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

http://www.wikidata.org/entity/Q34017518

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@ast

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@en

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@nl

type

label

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@ast

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@en

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@nl

prefLabel

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@ast

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@en

Ceftaroline: a novel broad-spe ...... sistant Staphylococcus aureus.

@nl

P1433

Q34017518-8171ACC6-694A-4B40-9ED3-3D43602317C1

P1476

Q34017518-F06C4D3B-84C7-4F41-B290-5F557CD72FE3

P2093

Q34017518-53F59575-BC78-4D7A-9C8A-9ED370A32977

Q34017518-5989C497-B070-47E5-BDB7-6912A6695BAE

Q34017518-6EDCD85F-6EE4-4AB1-9FDA-1807252817B5

Q34017518-A0E6CCEF-DCFF-47DC-81B6-5137F6187004

Q34017518-A68A1D0A-DF40-47F7-9F8A-B961AD441CAA

Q34017518-DC024C96-E041-4569-ABA9-245EAC21A14D

P2888

Q34017518-42A2906D-39F2-457A-94B7-1E3EEE53647C

P304

Q34017518-28F357A6-2171-48AD-8F96-58B8F23EC867

P31

Q34017518-CDFE1FEF-EA97-4E82-8294-FF56ED21BB6D

P356

Q34017518-D93E286E-4996-4D58-B4FD-215E33889E43

P433

Q34017518-9371BBFF-FC51-4015-ACFE-4E2C19777F4D

P478

Q34017518-29F9A4D4-EC52-47CF-A3CB-907BE331C270

P50

Q34017518-67AE5F3D-BB0E-4CC7-8F56-4EC92AF8A1CA

Q34017518-68CD2D33-A866-4717-9C88-A653351ECC8B

Q34017518-B3F6DFD7-4B77-4448-AE14-33743F42790B

P577

Q34017518-3340491A-8E49-42F1-B5A9-28D824B2688A

P6179

Q34017518-C173ED1E-A8A8-41E4-A687-B4CE8C978B49

P698

Q34017518-F0A639A9-670A-4A69-B490-3E35BF442C9C

P356

00003495-200969070-00003

P1433

P1476

Ceftaroline: a novel broad-spe ...... esistant Staphylococcus aureus

@en

P2093

Alfred S Gin

http://www.w3.org/2001/XMLSchema#string

Daryl J Hoban

http://www.w3.org/2001/XMLSchema#string

Ethan Rubinstein

http://www.w3.org/2001/XMLSchema#string

Frank Schweizer

http://www.w3.org/2001/XMLSchema#string

Grace Sniezek

http://www.w3.org/2001/XMLSchema#string

James A Karlowsky

http://www.w3.org/2001/XMLSchema#string

P2888

00003495-200969070-00003

P304

809-831

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/00003495-200969070-00003

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Sheryl A. Zelenitsky

Philippe Lagacé-Wiens

George G Zhanel

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028367278

http://www.w3.org/2001/XMLSchema#string

P698

19441869

http://www.w3.org/2001/XMLSchema#string